AASLD - Hepatitis Conference - Liver Conference - HCV - HepC - HBV - HepB
A Smart + Strong Site
Subscribe to:
Hepatitis E-newsletter
Join Us:
HIGHLIGHTS
What you need to know
> Blogs > Hep Exclusives > Hepatitis News > Lessons


Undetectable HCV Viral Load Reduces Liver Deaths

Reaching an undetectable viral load is linked to diminished chances of liver disease and liver-related death.



First Hep C Interferon-Free Treatment Submitted in Japan

BMS is looking for approval of the dual combination therapy of daclatasvir and asunaprevir.



Cure-All for Genotype 1

Sofosbuvir/Ledipasvir combo with ribavirin or GS-0669 cures 100% of hard-to-treat hep C cases.


AbbVie Double Combo Cures 90 to 95%

Interferon- and ribavirin-free combination therapy did well against genotype 1b in a recent study.



New Option for HCV/HIV Coinfected

An all-oral, interferon-free, 12- or 24-week hepatitis C regimen did well in a recent advanced trial.



Post-Transplant, Promising Results

Cure results from sofosbuvir and ribavirin combo given to hepatitis C patients with liver transplants suggest vast treatment improvements.


High Cure Rates for Geno 2 and 3

Sofosbuvir boasted high cure rates when given in combination with ribavirin.



92% Cure for Genotypes 1a & 1b

BMS interferon- & ribavirin-free triple combo boasts high cure rates among treatment-naive HCV patients.



AASLD 2013 Kicks Off in DC

Learn more about the 64th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD).

NEWSFEED
AASLD Coverage
Viread Safely Prevents Mother-to-Child Transmission of Hep B

Promising Early Results for Boehringer Ingelheim Hep C Combo

Incivek Improves Outcomes for HIV/HCV Coinfected Gay Men

Sofosbuvir Taken Before Transplant Lowers Hep C’s Return Rate

Sofosbuvir/Ledipasvir Combo Cures 97% of Hep C Genotype 1

Sofosbuvir, Ledipasvir Cure All of Hard-to-Treat Hep C Cases

Post-Transplantees Achieve Promising Results From Sofosbuvir

BMS Triple Combo Cures More than 90% of Genotypes 1a & 1b

Simeprevir and Sofosbuvir Cure Hep C Genotype 1 at High Rates

AbbVie Double Combo Cures 90 to 95% of Genotype 1b

High Cure Rates From Sofosbuvir, Ribavirin for Genotypes 2 & 3

Sofosbuvir and Ribavirin Fare Well Among HIV-HCV Coinfected

BMS Submits First Interferon-Free Hep C Treatment in Japan

Simeprevir Bests Current Hep C Drugs For Genotype 1

> More Newsfeed
HEP TV
Footage from the front lines
This video by Dr. Joseph Galati outlines the basic facts about hepatitis C, and a call to action to get tested and evaluated for treatment. Learn more about Dr. Galati at www.texasliver.com.
> More Hep TV
TALK TO US
Tell us what you think
Poll
Have you ever experienced digestive troubles while on hep C treatment?
Yes
No


Survey
Hepatitis C Reader Survey
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.